The Recall Desk
ModerateFDA (Food)·F-1101-2019·Announced 2019-03-06

Klaire Labs Melatonin Lozenge Formula Recalled Due to Incorrect Ingredient

ProThera, Inc. is recalling 120 bottles of Klaire Labs Melatonin Lozenge Formula because the product was filled with L-Theanine instead of melatonin.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The hazard involves a labeling/filling error where the wrong ingredient (L-Theanine) was used, which is a minor labeling or formulation error without reported illness.

Plain-English summary

ProThera, Inc. dba SFI USA is recalling 120 bottles of Klaire Labs Melatonin Lozenge Formula Fast Dissolving 1 mg tablets. The recall was initiated because a small quantity of the product labeled as Melatonin Lozenge Formula was filled with L-Theanine instead of the intended ingredient.

The affected product is packed in a 75 cc HDPE Bottle containing 60 tablets. The specific lot number is FG Lot 2018410057, with an expiration date of 8/2020. The product was distributed to one customer in Kansas.

Consumers who have purchased this product should check their inventory for the specific lot number and expiration date listed above. If they possess the affected product, they should stop using it and contact the recalling firm for instructions on how to return the product or obtain a refund.

The recalled product

Product
Klaire Labs Melatonin Lozenge Formula Fast Dissolving 1 mg tablets; Packed in a 75 cc HDPE Bottle 60 Tablets UPC: 8 28054 17845 8; SKU: ML1
Affected units
120

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • FG Lot 2018410057
  • Expiration Date 8/2020

Distribution

Distributed in 1 state:

Same manufacturer · ProThera, Inc. dba SFI USA

See all →